Article in Contract Pharma
Contract Pharma has reached out to Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, for a Q+A session, seeking her expertise on the lentiviral vector market.
In the resulting article Natalia addresses the current state of the market, challenges associated with lentiviral vectors, optimization for commercial-scale manufacturing, and the necessary adaptations for predicted growth in the industry.
You can read the full article here: https://www.contractpharma.com/contents/view_online-exclusives/2023-11-21/meeting-growing-demand-in-the-global-lentiviral-vector-market/